More on DNLI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (8.8 Score)

Upcoming Events

- Earnings (7/31/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Denali Therapeutics (NQ:DNLI)
Delayed: 19.69 -0.01 (0.05%)
Prev. Close $19.70  
Open$19.46 
52 Wk High$ 
52 Wk Low$ 
Day High$19.76 
Day Low$19.05 
P/E N/A  
EPS$ 
Volume1,260,862 

Friends, Peers and Foes (?): RPRX, ABBV, ARVN, ASND, ATYR (more...)

Mar 2, 2026 05:08 PM Jefferies Reiterates Buy Rating on Denali Therapeutics Inc. (DNLI)
Feb 27, 2026 07:26 AM Denali Therapeutics Inc. (DNLI) PT Lowered to $34 at Stifel
Feb 26, 2026 05:21 PM Denali Therapeutics Inc. (DNLI) Tops Q4 EPS by 2c
Feb 26, 2026 04:17 PM Form 10-K Denali Therapeutics Inc. For: Dec 31
Feb 26, 2026 04:13 PM Form S-8 Denali Therapeutics Inc.
Feb 26, 2026 04:11 PM Form 8-K Denali Therapeutics Inc. For: Feb 26
Feb 26, 2026 04:01 PM Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Feb 23, 2026 04:05 PM Wolfe Research Starts Denali Therapeutics Inc. (DNLI) at Peerperform
Feb 19, 2026 08:30 AM Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
Feb 5, 2026 04:14 PM Form 144 Denali Therapeutics Inc. Filed by: Ho Carole
View All Articles

Entities mentioned with DNLI

View All Entities